anabasine has been researched along with Atherosclerotic Parkinsonism in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chavez-Noriega, LE; Cosford, ND; Holsenback, H; Lloyd, GK; McDonald, IA; Menzaghi, F; Rao, TS; Reid, R; Sacaan, AI; Suto, CM; Urrutia, A; Vernier, JM; Washburn, MS; Whitten, JP | 1 |
1 other study(ies) available for anabasine and Atherosclerotic Parkinsonism
Article | Year |
---|---|
Conformationally restricted analogues of nicotine and anabasine.
Topics: Anabasine; Animals; Antiparkinson Agents; Calcium; Cell Line; Cholinergic Agonists; Drug Design; Humans; Macromolecular Substances; Molecular Conformation; Neurons; Nicotine; Parkinson Disease, Secondary; Piperidines; Pyridines; Recombinant Proteins; Structure-Activity Relationship; Transfection | 1998 |